The Department of Veterans Affairs is conducting market research to identify qualified sources capable of supplying Fluorodeoxyglucose 18 (FDG) radiopharmaceuticals for PET/CT scans at the Philadelphia VA Medical Center. The contractor must deliver doses to the Nuclear Medicine section at 3900 Woodland Avenue, Philadelphia, PA, with routine deliveries by 8:00 AM the next business day and priority orders within two hours. The contractor must label all packages as radioactive, accept unused doses for full credit, and provide a compatible NMIS system if needed. Responses are for market research only and do not constitute offers; no solicitation is currently available. Respondents bear all costs of response.